Methotrexate 7.5mg | METROTREX 7.5

Methotrexate 7.5mg is a low-dose, once-weekly disease-modifying antirheumatic drug (DMARD) prescribed primarily for rheumatoid arthritis, psoriasis, and psoriatic arthritis. It works by suppressing overactive immune and inflammatory pathways, slowing joint damage and reducing skin plaque formation. Methotrexate 7.5mg is a Schedule H prescription-only medicine and must never be taken daily — it is dosed once a week, typically alongside folic acid supplementation to reduce toxicity risk. Common side effects include nausea, fatigue, and mouth sores; serious risks include liver toxicity and bone marrow suppression, which is why regular blood monitoring is mandatory throughout treatment.

What Is Methotrexate 7.5mg?

Methotrexate 7.5mg is an oral tablet formulation of methotrexate, a folate antagonist that belongs to the DMARD (disease-modifying antirheumatic drug) class at low doses and the antimetabolite/antineoplastic class at higher oncology doses. At the 7.5mg strength, methotrexate is almost exclusively used for non-cancer, immune-mediated inflammatory conditions — most commonly rheumatoid arthritis and moderate-to-severe plaque psoriasis.

Unlike most oral medicines that are taken daily, methotrexate 7.5mg for these indications is administered once weekly, on the same day each week. This distinction is critical: taking methotrexate daily by mistake is a well-documented and potentially fatal dosing error. Patients starting this medicine should have their weekly dosing day clearly written on their prescription and packaging.

How Methotrexate 7.5mg Works 

Methotrexate interferes with folate metabolism, which in turn dampens the rapid cell division and inflammatory signaling seen in autoimmune conditions. At low, once-weekly doses, its primary action is not cell-killing (as in cancer therapy) but immunomodulatory — reducing the activity of inflammatory cytokines and immune cells that drive joint and skin damage.

1. Inhibits dihydrofolate reductase (DHFR) – Blocks conversion of folic acid into its active form, limiting DNA synthesis in rapidly dividing immune cells.
2. Reduces pro-inflammatory cytokine release – Lowers levels of inflammatory mediators involved in joint swelling and skin plaque formation.
3. Increases adenosine release – Adenosine has anti-inflammatory effects that help ease joint pain and stiffness.
4. Slows synovial and epidermal cell proliferation – Helps control joint lining inflammation in RA and reduces excessive skin cell turnover in psoriasis.

Clinical Indications

Dosage Guidelines

Key Benefits of Methotrexate 7.5mg

• Slows or halts progressive joint damage in rheumatoid arthritis
• Reduces joint swelling, stiffness, and pain over time
• Improves skin clearance in moderate-to-severe psoriasis
• Well-established long-term safety profile at low weekly doses when monitored properly
• Often used in combination with biologics for enhanced disease control
• Widely available, cost-effective DMARD option compared to newer biologic therapies

Precautions

• Never take methotrexate daily — confirm the once-weekly schedule with your doctor and pharmacist
• Avoid alcohol, which increases liver toxicity risk
• Contraindicated in pregnancy and breastfeeding due to teratogenic risk; reliable contraception is required for both partners during and after treatment as advised by the physician
• Regular blood tests (liver function, kidney function, complete blood count) are mandatory throughout treatment
• Inform your doctor of all medicines, including NSAIDs and certain antibiotics, which can increase methotrexate toxicity
• Avoid live vaccines during treatment
• Use caution in patients with pre-existing liver, kidney, or lung disease

Common Side Effects

• Nausea and stomach upset
• Fatigue or low energy
• Mouth ulcers or sores
• Headache
• Mild hair thinning
• Loss of appetite

Serious Side Effects 

• Signs of liver damage — yellowing of skin/eyes, dark urine
• Unusual bruising or bleeding (possible bone marrow suppression)
• Persistent dry cough or breathlessness (possible lung toxicity)
• Signs of infection — fever, chills, sore throat
• Severe mouth ulcers or gastrointestinal bleeding

Methotrexate 7.5mg vs Other DMARD Options

Key Statistics

Frequently Asked Questions 

Is methotrexate 7.5mg taken daily or weekly?

Methotrexate 7.5mg for rheumatoid arthritis or psoriasis is taken once a week, not daily. Taking it daily can cause serious toxicity.

What is methotrexate 7.5mg used for?

It is mainly used to treat rheumatoid arthritis, psoriatic arthritis, and moderate-to-severe plaque psoriasis by reducing inflammation and immune overactivity.

Why do doctors prescribe folic acid with methotrexate?

Folic acid helps reduce common side effects like nausea, mouth ulcers, and liver strain caused by methotrexate's effect on folate metabolism.

How long does methotrexate 7.5mg take to work?

Most patients notice improvement within 4 to 6 weeks, though full benefits may take up to 12 weeks of consistent therapy.

Can methotrexate 7.5mg be taken during pregnancy?

No. Methotrexate is contraindicated during pregnancy and breastfeeding due to the risk of birth defects and should be stopped well in advance under medical guidance if pregnancy is planned.

What blood tests are needed while on methotrexate?

Regular liver function tests, kidney function tests, and complete blood counts are required to monitor for toxicity throughout treatment.

Is methotrexate 7.5mg safe for long-term use?

Yes, when properly monitored with routine blood tests and appropriate folic acid supplementation, low-dose weekly methotrexate is considered safe for long-term disease management.

Conclusion

Methotrexate 7.5mg remains one of the most trusted and widely prescribed foundation therapies for rheumatoid arthritis, psoriatic arthritis, and plaque psoriasis. Its once-weekly dosing schedule, combined with folic acid support and regular blood monitoring, allows patients to manage chronic inflammatory conditions effectively while minimizing risk. As with any DMARD, methotrexate 7.5mg should only be used under the guidance of a qualified physician, with strict adherence to the prescribed weekly schedule and monitoring plan.

Prescription only – consult your doctor

Brand name: Metrotrex 7.5
Composition: Methotrexate Tablets USP 7.5mg
Formulation: Oral tablet
Pack size: 10×10 tablets (strip of 10 tablets per strip, 10 strips per box)
Marketed By: Steris Healthcare Pvt Ltd
Regulatory standard: WHO-GMP certified
Schedule: Rx — Valid Prescription Required